Evolve Biologics Inc. offers the development and commercialization of plasma-derived therapeutics, using its proprietary PlasmaCap EBA purification technology to more efficiently and effectively meet growing global patient demand for these life-saving products. The Company is currently in the process of commercializing an exciting and innovativeportfolio of product candidates, including IVIG (intravenous immunoglobulin) and Albumin (human serum albumin), both of which are in advanced stages of regulatory approval in the US (FDA) and Canada (Health Canada).

Health Care

Biotechnology

Evolve Biologics

James Caggiano

Trevor Seelert, P. Eng

Madhuja Gupta

Mark Krause

Kelly McNeely

Gillian Vanderlee

Domenic Rizzuto

David Holliday

Dave Miller

Chris Carr

Carolyn Koerner

The Facility and Operations Team at Evolve Biologics Inc. is responsible for managing and optimizing the company's commercial facilities and supply chain operations. This includes overseeing the infrastructure required for PlasmaCap EBA purification technology, ensuring regulatory compliance, and ensuring seamless production and distribution of plasma-derived therapeutics like IVIG and Albumin. The team works to maintain operational excellence and support the commercialization of Evolve Biologics' innovative product portfolio.

Facility and Operations Team

Laboratory and Research

Leadership Team

��

Facility and Operations Team

About

Team members

Other teams at Evolve Biologics

Laboratory and Research

Leadership Team

��������

Facility and Operations Team

About

Team members

Other teams at Evolve Biologics

Laboratory and Research

Leadership Team

��